Prenetics Global Limited
PRENASDAQHealthcareDiagnostics & Research
As of Oct 22, 2026 close
- Market cap
- $286.10M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $11.37$27.24
- Volume (live)
- -
- Avg. volume (3M)
- 193.74K
Prenetics Global (PRE) Stock Price & Financial Analysis
Prenetics Global Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $16.03 - $17.56 |
|---|---|
| 52-Week High | $27.24 |
| 52-Week Low | $11.37 |
| Open | $16.78 |
| Volume (last close) | 290.29K |
| Average Volume (3M) | 193.74K |
| Revenue (TTM) | 142.56M |
|---|---|
| Net Income (TTM) | -67.61M |
| Free Cash Flow (TTM) | -70.81M |
| EPS (TTM) | −$4.21 |
| Profit Margin | -47.43% |
| Operating Margin | -35.48% |
| Return on Equity (ROE) | -72.76% |
| Debt to Equity | 0.01 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Market Cap | 286.10M |
|---|---|
| Shares Outstanding | 17.27M |
| Price to Sales (P/S) | 2.01 |
| Price to Book (P/B) | 3.08 |
| EV/EBITDA | -3.64 |
| 50-Day MA | $22.27 |
|---|---|
| 200-Day MA | $19.52 |
| 1-Year Change | −4.66% |
Source: Market prices and company fundamentals. Data as of Oct 22, 2026. Data sources and methodology
Prenetics Global at a Glance
As of the Oct 22, 2026 close, Prenetics Global (PRE) has a market capitalization of $286.10M. The stock trades at 2.0× sales. Over the trailing twelve months it lost $67.61M on revenue of $142.56M and burned $70.81M of free cash flow. Revenue grew 199.8% year over year.
As of its latest reported balance sheet, it holds $59.05M in cash and securities against $682.00K of debt, a net cash position of $58.37M.
Prenetics Global does not currently pay a dividend.
The share price is down 4.7% over the past year. At $16.57 (the Oct 22, 2026 close) it sits within its 52-week range of $11.37 to $27.24, below its 200-day moving average of $19.52.
Based on 6 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $40.40, 143.8% above the Oct 22, 2026 close.
Frequently Asked Questions About Prenetics Global
What is the current stock price for PRE?
As of the Oct 22, 2026 close, PRE stock trades at $16.57. The 52-week range is $11.37–$27.24, with a day range of $16.03–$17.56.
What is the P/E ratio for PRE?
The P/E ratio (Price-to-Earnings) for PRE is shown in the Key Statistics section. This valuation metric helps compare Prenetics Global Limited to industry peers.
Does PRE pay dividends?
Prenetics Global does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for PRE?
Based on ratings from 6 professional analysts over the last 90 days, the consensus for PRE is Buy. The average 12-month price target is $40.40, a 143.8% upside from the Oct 22, 2026 close of $16.57.
What is the market cap of PRE?
As of the Oct 22, 2026 close, Prenetics Global's market capitalization is $286.1M, classifying it as a micro-cap company. Prenetics Global operates in the Healthcare sector within the Diagnostics & Research industry.